CONSULTING

Clinical and Professional Consulting Services

CLINICAL CONSULTING SERVICES

Dr Parker provides clinical consulting services for persons affected by hearing loss and/or their significant others. Contact him if you want individualized hearing healthcare delivered to you, if you have bothersome tinnitus, or if you have tried hearing aids in the past and they are in your drawer instead of your ear.

He would love to help you.

PROFESSIONAL CONSULTING SERVICES

Dr Parker provides professional consulting services for businesses, venture capitalists, and other investment groups seeking an independent analysis of basic and clinical data related to the treatment of hearing loss.

Contact him if you want an independent analysis of public or private data related to conventional hearing aids and biological treatments for hearing loss such as drug, gene, and cell-based therapies.

PROFESSIONAL CONSULTING EXPERIENCE

2024-curr Audiology Consultant on an R21 “Role of connectivity between hippocampus/medial temporal lobe and auditory cortex in adverse listening conditions”

2023-curr:      Subject Expert for an Over-the-Counter Hearing Aid manufacturer

2021-2022: Subject Expert for a Pharmaceutical company: clinical analysis of tinnitus side effects in internal clinical trial data

2021-curr: Technical Advisory Board Member for Lucid Hearing

2021: Subject Expert for a Venture Capital Group: clinical analysis of raw unpublished clinical trial data on hair cell regeneration

2021: Subject Expert for a Venture Capital Group A: clinical analysis of public clinical trial data on hair cell regeneration

2021: Subject Expert for a Venture Capital Group B: clinical analysis of public clinical trial data on hair cell regeneration

2021: Subject Expert for a Venture Capital Group C: clinical analysis of public clinical trial data on hair cell regeneration

2021: Subject Expert for a Venture Capital Group D: clinical analysis of public clinical trial data on hair cell regeneration

2021: Subject Expert for a Venture Capital Group E: clinical analysis of public clinical trial data on hair cell regeneration

2020: Subject Expert for a Venture Capital Group: hearing aid treatment for sensorineural hearing gloss

2019: Subject Expert for a Venture Capital Group A: drug therapy for hearing loss

2019: Subject Expert for a Venture Capital Group B: drug therapy for Meniere’s disease

2018: Subject Expert for a Venture Capital Group: drug treatment for hair cell regeneration

  • non-disclosure agreements prevent the identification of these companies.